ESLT ESLT
Company Profile ↓Company Overview
ESLT (ESLT) is a publicly traded company listed on with a market capitalization of $40.14B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 24.7% per year over the last five years.
Revenue has grown at a 12.9% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.23.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $7.94B (+16.3% YoY); net profit $534.34M.
- Trailing 12 Months Year-on-year growth — revenue +16.3%, earnings +66.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 12.9%, profit CAGR 24.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 12.93% |
| 1 Year: | 16.27% |
Compounded Profit Growth
| 5 Years: | 24.72% |
| 1 Year: | 66.39% |
Stock Price Performance
| 1 Year: | +77.29% |
| 6 Months: | +20.32% |
| 3 Months: | +1.66% |
| 1 Month: | +11.10% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)64.85 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 12.9% over 5 years.
- Profit CAGR of 24.7% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 75.9.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 1.90B | 1.97B | 1.92B | 2.15B | 2.19B |
| Cost of Revenue | 1.44B | 1.50B | 1.44B | 1.62B | 1.64B |
| Gross Profit | 454.31M | 472.91M | 478.24M | 529.79M | 552.06M |
| Operating Expenses | 304.60M | 315.09M | 306.81M | 321.57M | 346.93M |
| Operating Income | 149.71M | 157.82M | 171.43M | 208.22M | 205.13M |
| EBITDA | 196.53M | 199.85M | 216.36M | 192.18M | 252.67M |
| Interest Expense | 38.96M | 31.17M | 34.46M | -33.01M | 32.19M |
| Pretax Income | 115.70M | 125.30M | 138.33M | 182.59M | 174.66M |
| Tax Provision | 16.06M | 7.06M | 11.41M | 21.01M | 22.77M |
| Net Income | 107.08M | 125.70M | 133.40M | 168.16M | 160.79M |
| Diluted EPS | 2.35 | 2.69 | 2.80 | 3.52 | 3.34 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 5.51B | 5.97B | 6.83B | 7.94B |
| Cost of Revenue | - | 4.14B | 4.49B | 5.19B | 6.00B |
| Gross Profit | - | 1.37B | 1.48B | 1.64B | 1.94B |
| Operating Expenses | - | 1.01B | 1.12B | 1.13B | 1.25B |
| Operating Income | - | 362.93M | 362.51M | 509.96M | 687.18M |
| EBITDA | - | 495.00M | 488.62M | 632.80M | 804.92M |
| Interest Expense | - | 41.15M | 97.32M | 132.67M | 71.57M |
| Pretax Income | - | 292.56M | 226.49M | 341.75M | 561.91M |
| Tax Provision | - | 24.13M | 22.91M | 39.06M | 55.54M |
| Net Income | - | 275.45M | 215.13M | 321.14M | 534.34M |
| Diluted EPS | - | 6.18 | 4.82 | 7.18 | 11.39 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 9.22B | 9.74B | 10.97B | 12.66B |
| Current Assets | - | 5.03B | 5.51B | 6.36B | 7.74B |
| Cash & Equivalents | - | 211.11M | 197.43M | 265.35M | 635.14M |
| Inventory | - | 1.69B | 2.03B | 2.36B | 2.73B |
| Receivables | - | 983.29M | 767.09M | 1.01B | 1.24B |
| Total Liabilities | - | 6.46B | 6.79B | 7.69B | 8.53B |
| Current Liabilities | - | 4.28B | 4.82B | 5.31B | 5.98B |
| Long Term Debt | - | 680.08M | 384.07M | 305.92M | 255.62M |
| Total Debt | - | 1.29B | 1.47B | 1.37B | 964.81M |
| Total Equity | - | 2.76B | 2.95B | 3.28B | 4.13B |
| Shares Outstanding | - | 44.34M | 44.45M | 44.55M | 46.44M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 240.07M | 113.71M | 534.61M | 778.38M |
| Investing Cash Flow | - | -151.98M | -210.60M | -178.83M | -390.72M |
| Financing Cash Flow | - | -135.97M | 83.21M | -287.85M | -17.87M |
| Capital Expenditure | - | -205.11M | -187.04M | -215.05M | -225.57M |
| Free Cash Flow | - | 34.96M | -73.33M | 319.56M | 552.81M |
| Net Change in Cash | - | -47.88M | -13.68M | 67.92M | 369.79M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 24.9% | 24.8% | 24.0% | 24.4% |
| Operating Margin % | - | 6.6% | 6.1% | 7.5% | 8.7% |
| Net Margin % | - | 5.0% | 3.6% | 4.7% | 6.7% |
| ROE % | - | 10.0% | 7.3% | 9.8% | 12.9% |
| ROCE % | - | 7.3% | 7.4% | 9.0% | 10.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ESLT
Axon Enterprise (AXON) Q2 Earnings Miss Estimates
Axon (AXON) delivered earnings and revenue surprises of -0.53% and +4.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Elbit Systems Wins More Than $370 Million in CBP Contracts Through 2029
Elbit Systems (NASDAQ:ESLT) announced that its U. S.
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Key Earnings Reports
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.5%, and the actively tra
Elbit Systems of America Awarded Contracts from U.S. Customs and Border Protection Totaling Over $370 Million to Enhance U.S. National Security
Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced today that its U.S. subsidiary, Elbit Systems of America, LLC ("Elbit America"), has received multiple awards from U.S. Customs and Border Protectio…
Elbit Systems to Report Second Quarter 2026 Financial Results on August 11, 2026
Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced today that it will publish its second quarter 2026 financial results on Tuesday, August 11, 2026.
Odysight.ai Receives Purchase Order from Elbit Systems on Behalf of the Israeli Ministry of Defense for Deployment of Its Vision-Based Prognostics and Health Management System
The purchase order, valued at approximately $0.3 million (NIS 1.0 million), expands Odysight.ai’s operational portfolio and may lead to wide deployment across the Israeli Defense Forces upon successful completion Ramat Gan, Israel, July 08,…
ESLT — Frequently Asked Questions
What is the current share price of ESLT?
As of 2026-08-05 17:25 PDT, ESLT trades at $864.26 on NASDAQ/NYSE. Its 52-week range is $434.92 to $1,011.93.
What is the market capitalisation of ESLT?
ESLT has a market capitalisation of $40.14B on NASDAQ/NYSE.
What is the P/E ratio of ESLT?
ESLT trades at a trailing price-to-earnings (P/E) ratio of 75.88. Its price-to-book (P/B) ratio is 9.72.
What is the return on equity (ROE) of ESLT?
ESLT has a return on equity (ROE) of 12.94%. Its return on capital employed (ROCE) is 10.28%.
Is ESLT a good stock to buy?
This page provides a data-driven analysis of ESLT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.